Showing 18,961 - 18,980 results of 30,969 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 2 step decrease ))', query time: 1.13s Refine Results
  1. 18961

    Time-resolved UV-visible spectroscopy of bodipy-based materials by F Cucinotta (7836197)

    Published 2017
    “…The first set of materials is characterised by green luminescence that, as the dye loading increases from 1% to 50%, shows a decrease in quantum yields from 0.22 to 0.05 and a reduction of the excited state lifetime. …”
  2. 18962

    Igf signaling is required for cardiomyocyte proliferation during zebrafish heart development. by Ying Huang (53474)

    Published 2013
    “…E. A significant decrease (***<i>p</i><0.0001) in cardiomyocyte proliferation was detected in embryos treated with NVP-AEW541.…”
  3. 18963

    Synthesis and bioactivity of the γ-secretase modulator photo-probe AR243. by Thorsten Jumpertz (188948)

    Published 2012
    “…AR243 caused a dose-dependent decrease in Aβ42 levels with a concomitant increase in Aβ38 levels, confirming its bioactivity as a potent GSM with an IC<sub>50</sub> for Aβ42 reduction of 290 nM.…”
  4. 18964

    Table1_The electrocardiographic, hemodynamic, echocardiographic, and biochemical evaluation of treatment with edaravone on acute cardiac toxicity of aluminum phosphide.XLSX by Nader Rahimi Kakavandi (13908558)

    Published 2022
    “…The rats were divided into six groups, including almond oil (control), normal saline, AlP (LD<sub>50</sub>), and AlP + EDA (20, 30, and 45 mg/kg). …”
  5. 18965

    DataSheet_6_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.csv by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  6. 18966

    DataSheet_1_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.pdf by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  7. 18967

    DataSheet_5_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.xlsx by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  8. 18968

    DataSheet_7_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.xlsx by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  9. 18969

    DataSheet_4_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.xlsx by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  10. 18970

    DataSheet_3_Evaluating NetMHCpan performance on non-European HLA alleles not present in training data.xlsx by Thomas Karl Atkins (17791715)

    Published 2024
    “…Thus, investigating the composition of training datasets used in machine learning models with healthcare applications is vital to ensure equity. Two such machine learning models are NetMHCpan-4.1 and NetMHCIIpan-4.0, used to predict antigen binding scores to major histocompatibility complex class I and II molecules, respectively. …”
  11. 18971

    Table 6_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  12. 18972

    Table 3_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  13. 18973

    Table 1_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  14. 18974

    Table 4_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  15. 18975

    Data Sheet 1_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.docx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  16. 18976

    Table 5_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  17. 18977

    Rheological behavior of concentrated tucupi by Telma dos Santos COSTA (4618960)

    Published 2018
    “…Rheology at 25 °C indicated that the partial gelification of starch during concentration causes a decrease in the product’s viscosity and, if the concentration is carried out at a temperature that favors total starch gelification, the product’s viscosity increases. …”
  18. 18978

    Rheological behavior of concentrated tucupi by Telma dos Santos COSTA (4618960)

    Published 2019
    “…Rheology at 25 °C indicated that the partial gelification of starch during concentration causes a decrease in the product’s viscosity and, if the concentration is carried out at a temperature that favors total starch gelification, the product’s viscosity increases. …”
  19. 18979

    Blind Predictions of DNA and RNA Tweezers Experiments with Force and Torque by Fang-Chieh Chou (414477)

    Published 2014
    “…These calculations recovered the experimental bending persistence length of dsRNA within the error of the simulations and accurately predicted that dsRNA's “spring-like” conformation would give a two-fold decrease of stretch modulus relative to dsDNA. …”
  20. 18980

    Simulated temporal dynamics in E2F activation using the stochastic Rb-E2F model. by Tae J. Lee (241477)

    Published 2010
    “…<p>(A) Stochastic simulations (25 events) exhibit variable time delays in E2F activation, as shown in gray lines. …”